Adalimumab Biosimilars and Access Barriers in Dermatology

Published: 22 June 2026| Version 1 | DOI: 10.17632/9ccxz4rj8v.1
Contributors:
, Nicole Baker, Anisah Alladeen, Haya A, Raj Chovatiya, Diego Dasilva, G. Michael Lewitt, Peter Lio, Harrison Nguyen, James Song, Susan Taylor, Nicholas Mollanazar

Description

Supplemental table containing information regarding patient assistance programs for Adalimumab and Adalimumab biosimilars.

Files

Categories

Dermatology

Licence